INTERIM REPORT JULY-SEPTEMBER 2022
SUMMARY OF THE INTERIM REPORT During the third quarter, sales in regular wound healing products amounted to MSEK 0.8 (0.7). The Group's net turnover during the quarter amounted to MSEK 0.8 (0.7). Costs increased compared to the same period last year. The increase of costs is mainly attributable to increased currency losses as a result of a weak krona as well as salary costs and travel costs, which is partly a consequence of increased activity within the company after the years of the pandemic. However, costs are lower than the first and the second quarter of the current year.